PSA Screening for HIM Act
Bill Summary
Requires Medicare to cover prostate-specific antigen (PSA) blood tests for men, helping with early detection of prostate cancer. Funds these screenings without additional cost to the patient.
Sponsored By
Bill Journey
- Jan 29, 2025
- Mar 19, 2026You Are Here
The bill was sent to committee, where members study it, hold hearings, and decide whether to advance it.
- TBD
The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.
- TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
- TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
- TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.
Why It Matters
This bill affects male Medicare beneficiaries, providing them with free access to PSA screenings to detect prostate cancer early. It particularly impacts older men, as prostate cancer risk increases with age.
Impact Areas
Support & Opposition
- Democratic6
- Republican1
Documents
1
Full text opens on congress.gov, the official source.
Cosponsors (6)
Bill Details
- Health
Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.






